Blog & News

The transformative impact of NLG on Pharma

By Amy McCloskey Tobin | March 11, 2022
Blog Image - 01 The transformative impact of NLG on Pharma

Natural language generation (NLG) improves the ability of a business to analyze and understand its data with 100% accuracy, speed, and capacity to scale. Pharmaceutical companies are realizing these benefits across departments, including: 

  • Business Intelligence Insights
  • A Enterprise Reporting
  • Clinical Safety Reports
  • Clinical Trial Management
  • Compliance/Regulatory Reporting
  • Prescription Label Automation
  • Logistics and Distribution
  • COVID-19 Analytics

Report automation for Life Sciences has evolved 

Timely, accurate data analysis is critical to bringing life-saving products to market. Arria NLG’s business intelligence for Life Sciences analyzes and explains pharmaceutical and biotechnology dashboards as narrative data stories. Instant understanding is consistent for dashboard users, bringing data literacy to the entire organization. 

“Partnering with Arria to provide our clients with a way to automate the writing of medical and regulatory reports was a natural choice. NLG allows companies to save significant time and money while increasing scalability and efficiency. Arria’s breakthrough technology will transform the way our customers bring lifesaving drugs to market.”

~Dr. Ray Glemser, CEO, Glemser Technologies

NLG for reporting in pharma

Arria NLG is easily integrated with your existing Business Intelligence solution to analyze your data, and automatically describes data points that are unusual or striking. It performs variance analysis and generates narratives with key insights. NLG also automates insights to changes in data trends and summarizes the rankings of combinations of dimensions over a period.

Use case examples of how NLG is used in pharma include: 

  • Performance reporting
  • Opportunities analysis
  • Cost-benefit analysis
  • Consumer needs analysis
  • Market share report
  • Performance KPIs
  • Consumer activity analysis

Learn more at PharmaUSA

Arria is a gold sponsor and chairing the commercial track at Pharma USA, a one-stop-shop for discovering the answers to pharma’s biggest challenges, on March 16th-17th in Philadelphia. The conference will focus on market risks, provide attendees the opportunity to find partners, and hear from strategic and technical experts.  

Jay Dewalt, Arria’s Chief Operating Officer, is chairing the commercial track focusing on:  

Data-driven transformation: Turn your wealth of data into an insights-led business model that delivers unprecedented value for customers and drives improved business outcomes.

Attendees will include Finance Analysts, EVPs, Directors, Managers, CEOs, Chief Medical Officers, Global Digital and Analytics Leads, Heads of Innovation, and decision-makers from the pharmaceutical industry. 

If you would like to learn more about how NLG can improve business outcomes for pharma:

To attend Pharma USA, register here, and come say hello at Booth 223! 

“Arria’s built-in analytical and linguistic capabilities provide us with the technology to dramatically improve the speed and efficiency of our reporting. A key benefit for us is that we can use this powerful platform to create our own NLG applications within our department.”

                               ~Bryan O’Conner, Lead Director, Advanced Analytics GBS, AstraZeneca

Arria NLG is the recognized global leader in the field of natural language generation (NLG), a form of artificial intelligence specializing in extracting key insights from complex data sources and communicating that information in natural language. Arria NLG works with four of the top 10 pharmaceutical companies helping them increase and accelerate data understanding.